Moderna (MRNA) Cash from Investing Activities (QoQ) (2018 - 2026)
Moderna (MRNA) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Moderna | 21.94 Bn | 16.73 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.33% |
| Dec 31, 2025 | -106.86% |
| Sep 30, 2025 | 24.11% |
| Jun 30, 2025 | -22.74% |
| Mar 31, 2025 | 235.44% |
| Dec 31, 2024 | -174.76% |
| Sep 30, 2024 | -56.28% |
| Jun 30, 2024 | 1,297.46% |
| Mar 31, 2024 | 121.93% |
| Dec 31, 2023 | -168.19% |
| Sep 30, 2023 | -59.41% |
| Jun 30, 2023 | -3.33% |
| Mar 31, 2023 | 291.89% |
| Dec 31, 2022 | -210.90% |
| Sep 30, 2022 | 182.03% |
| Jun 30, 2022 | 70.62% |
| Mar 31, 2022 | -244.55% |
| Dec 31, 2021 | 65.80% |
| Sep 30, 2021 | 14.21% |
| Jun 30, 2021 | -2,054.44% |